Wolfgang Meyer‐Sabellek

Author

Charité - Universitätsmedizin Berlin

Also Known As

WOLFGANG MEYER-SABELLEK, Wolfgang Meyer-Sabellek, Wolfgang Meyer‐Sabellek

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Freie Universität Berlin Universität Hamburg AstraZeneca (Germany)Bayreuth Medical Center

About

Wolfgang Meyer‐Sabellek is an author at Charité - Universitätsmedizin Berlin specializing in medicine, cardiovascular disease, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	14	809
2	Health Sciences	3	3	52
3	Public Health	3	3	40
4	Allergy	2	2	48
5	Emergency Medicine	1	1	370

Wolfgang Meyer‐Sabellek

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens Rolf Schröder, Karl Wegscheider, Klaus Schröder, Journal of the American College of Cardiology ThrombosisSensitive MeasureThrombolytic RegimensCardiovascular DiseaseAtherosclerosis	1995	370
Risk Factors for Erosive Esophagitis: A Multivariate Analysis Based on the ProGERD Study Initiative Joachim Labenz, D Jaspersen, Michael Kulig, The American Journal of Gastroenterology	2004	189
Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial Disease Joachim Labenz, Marc Nocon, Tore Lind, The American Journal of Gastroenterology	2006	155
Association of body mass index with heartburn, regurgitation and esophagitis: Results of the Progression of Gastroesophageal Reflux Disease study Marc Nocon, Joachim Labenz, D Jaspersen, Journal of Gastroenterology and Hepatology	2006	104
Abnormal Bone Histology in Idiopathic Hypercalciuria * Hartmut H. Malluche, WOLFGANG TSCHOEPE, Eberhard Ritz, The Journal of Clinical Endocrinology & Metabolism UrologyAbnormal Bone HistologyBone ImagingRenal PathologyHistopathology	1980	97
Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator study Karl-Ludwig Neuhaus, R. von Essen, Albrecht Vogt, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseAtherosclerosisPharmacologyBm 06,022	1994	61
Alkaline phosphatase Wolfgang Meyer‐Sabellek, Pranav Sinha, Eckart Köttgen Journal of Chromatography B Biomedical Sciences and Applications	1988	54
Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction Ulrich Tebbe, R. von Essen, A. Smolarz, The American Journal of Cardiology Dose-finding StudyThrombosisCardiovascular DiseaseMedicineAnticoagulant	1993	51
Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD Henrik Watz, Daniel Bock, Michael C. Meyer, Pulmonary Pharmacology & Therapeutics InflammationPan-selectin Antagonist BimosiamoseInflammatory Lung DiseaseLung InflammationMedicine	2012	47
Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine Karl-Ludwig Schulte, Wolfgang Meyer‐Sabellek, K. Liederwald, The American Journal of Cardiology HypertensionHeart FailureBlood PressureCardiovascular DiseaseAmbulatory Blood Pressure	1992	35

Page 1